BR112014000547A2 - deoxycholic acid formulations and salts thereof - Google Patents
deoxycholic acid formulations and salts thereofInfo
- Publication number
- BR112014000547A2 BR112014000547A2 BR112014000547A BR112014000547A BR112014000547A2 BR 112014000547 A2 BR112014000547 A2 BR 112014000547A2 BR 112014000547 A BR112014000547 A BR 112014000547A BR 112014000547 A BR112014000547 A BR 112014000547A BR 112014000547 A2 BR112014000547 A2 BR 112014000547A2
- Authority
- BR
- Brazil
- Prior art keywords
- deoxycholic acid
- salts
- acid formulations
- less
- aqueous pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
resumo patente de invenção: "formulações de ácido desoxicólico e sais do mesmo". a presente invenção refere-se a uma composição farmacêutica aquosa consistindo em cerca de 0,4% m/v a menos de cerca de 2% m/v de um sal de ácido desoxicólico, em que a composição é mantida em um ph de cerca de 8,1 a cerca de 8,5 tal que a composição é estabilizada contra precipitação. são também descritos aqui métodos para estabilizar uma composição farmacêutica aquosa consistindo em cerca de 0,4% m/v a menos de cerca de 2% m/v de um sal de ácido desoxicólico contra precipitação, tal método consistindo na manutenção do ph da solução de cerca de 8,1 a cerca de 8,5.Patent Summary: "Deoxycholic acid formulations and salts thereof". The present invention relates to an aqueous pharmaceutical composition consisting of about 0.4% w / v and less than about 2% w / v of a deoxycholic acid salt, wherein the composition is maintained at a pH of about 8.1 to about 8.5 such that the composition is stabilized against precipitation. Also described herein are methods for stabilizing an aqueous pharmaceutical composition consisting of about 0.4% w / v and less than about 2% w / v of a precipitated deoxycholic acid salt, such a method consisting in maintaining the pH of the solution of deoxycholic acid. about 8.1 to about 8.5.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2011/048806 WO2013028177A1 (en) | 2011-08-23 | 2011-08-23 | Formulations of deoxycholic acid and salts thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112014000547A2 true BR112014000547A2 (en) | 2017-02-14 |
BR112014000547B1 BR112014000547B1 (en) | 2021-11-09 |
Family
ID=45569726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112014000547-8A BR112014000547B1 (en) | 2011-08-23 | 2011-08-23 | STABLE AQUEOUS COMPOSITION IN PRECIPITATION |
Country Status (18)
Country | Link |
---|---|
JP (1) | JP5919597B2 (en) |
KR (5) | KR101919269B1 (en) |
CN (3) | CN108619089A (en) |
AU (3) | AU2011375432B2 (en) |
BR (1) | BR112014000547B1 (en) |
CA (1) | CA2842177C (en) |
CR (1) | CR20140053A (en) |
EA (1) | EA029305B1 (en) |
IL (1) | IL230547A (en) |
IN (1) | IN2014CN02188A (en) |
MX (1) | MX350390B (en) |
MY (1) | MY184277A (en) |
NZ (1) | NZ620040A (en) |
PH (1) | PH12016501175B1 (en) |
SG (1) | SG2014013205A (en) |
UA (1) | UA113522C2 (en) |
WO (1) | WO2013028177A1 (en) |
ZA (1) | ZA201401027B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
CA3003746A1 (en) * | 2015-11-04 | 2017-05-11 | Kythera Biopharmaceuticals, Inc. | Treatments of accumulated fat with deoxycholic acid and salts thereof |
US20180078621A1 (en) * | 2016-09-22 | 2018-03-22 | Kyoung Lack Lee | Composition for hypotonic lipolysis and manufacturing method thereof |
KR101841193B1 (en) * | 2016-09-22 | 2018-03-22 | 이경락 | Composition for hypotonic lipolysis and manufacturing method thereof |
BR112020019192A2 (en) * | 2018-04-16 | 2021-01-05 | Penmix Ltd. | PHARMACEUTICAL COMPOSITION THAT UNDERSTANDS DEOXICOLIC ACID |
KR102172439B1 (en) * | 2018-12-05 | 2020-10-30 | 송미희 | Composition for lipolysis and injection composition comprising the same |
KR102064864B1 (en) | 2019-02-08 | 2020-01-10 | (주)제테마 | Topical injectable composition |
KR102111346B1 (en) * | 2019-08-20 | 2020-05-22 | 아영창 | Aqueous composition with sodium deoxycholate having improved stability against precipitation |
KR20220026068A (en) | 2020-08-25 | 2022-03-04 | 강명범 | Composition for lipolysis and injection composition comprising the same |
CN116617160A (en) * | 2023-07-25 | 2023-08-22 | 山东则正医药技术有限公司 | Aqueous suspension, preparation method, freeze-dried powder, application and fat reduction injection |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2754709B1 (en) | 1996-10-23 | 1999-03-05 | Sanofi Sa | COSMETIC COMPOSITION CONTAINING AN ANTAGONIST OF GAMMA NEUROPEPTIDE RECEPTORS AND ALPHA 2 ANTAGONISTS THAT MAY BE INCORPORATED IN SUCH A COMPOSITION |
EP1113785B1 (en) * | 1998-07-24 | 2005-04-13 | Seo Hong Yoo | Clear aqueous solutions of bile acids |
US6417179B1 (en) * | 1998-10-13 | 2002-07-09 | Craig G. Burkhart | Ear wax solution |
US20050048126A1 (en) * | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
DE10361067A1 (en) * | 2003-12-22 | 2005-07-14 | Aventis Pharma Deutschland Gmbh | Medicinal lipolysis of fat accumulations |
US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
ES2660172T3 (en) | 2004-05-19 | 2018-03-21 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Injectable composition comprising sodium deoxycholate |
US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
AU2006255097B2 (en) | 2005-06-06 | 2012-02-09 | Georgetown University | Compositions and methods for lipo modeling |
TW201011755A (en) | 2008-09-10 | 2010-03-16 | Skymedi Corp | Flash memory system and its data recovery method |
JP5420946B2 (en) * | 2009-03-23 | 2014-02-19 | 富士フイルム株式会社 | Minoxidil aqueous composition containing bile acids |
EP2645099A1 (en) | 2012-03-30 | 2013-10-02 | Phares Pharmaceutical Research N.V. | Biorelevant compositions |
-
2011
- 2011-08-23 NZ NZ620040A patent/NZ620040A/en not_active IP Right Cessation
- 2011-08-23 IN IN2188CHN2014 patent/IN2014CN02188A/en unknown
- 2011-08-23 KR KR1020177016779A patent/KR101919269B1/en active IP Right Grant
- 2011-08-23 KR KR1020187032491A patent/KR102034606B1/en active IP Right Grant
- 2011-08-23 EA EA201490175A patent/EA029305B1/en unknown
- 2011-08-23 SG SG2014013205A patent/SG2014013205A/en unknown
- 2011-08-23 CN CN201810400642.9A patent/CN108619089A/en active Pending
- 2011-08-23 MX MX2014001495A patent/MX350390B/en active IP Right Grant
- 2011-08-23 BR BR112014000547-8A patent/BR112014000547B1/en active IP Right Grant
- 2011-08-23 MY MYPI2014000197A patent/MY184277A/en unknown
- 2011-08-23 KR KR1020207002722A patent/KR20200013103A/en not_active Application Discontinuation
- 2011-08-23 CA CA2842177A patent/CA2842177C/en active Active
- 2011-08-23 WO PCT/US2011/048806 patent/WO2013028177A1/en active Application Filing
- 2011-08-23 KR KR1020197030233A patent/KR102073536B1/en active IP Right Grant
- 2011-08-23 CN CN201180072842.2A patent/CN103826608A/en active Pending
- 2011-08-23 UA UAA201400641A patent/UA113522C2/en unknown
- 2011-08-23 JP JP2014527128A patent/JP5919597B2/en active Active
- 2011-08-23 CN CN201810403291.7A patent/CN108743522A/en active Pending
- 2011-08-23 AU AU2011375432A patent/AU2011375432B2/en active Active
- 2011-08-23 KR KR1020147006855A patent/KR101751585B1/en active IP Right Review Request
-
2014
- 2014-01-20 IL IL230547A patent/IL230547A/en active IP Right Grant
- 2014-01-30 CR CR20140053A patent/CR20140053A/en unknown
- 2014-02-10 ZA ZA2014/01027A patent/ZA201401027B/en unknown
-
2016
- 2016-04-27 AU AU2016202661A patent/AU2016202661B2/en active Active
- 2016-06-16 PH PH12016501175A patent/PH12016501175B1/en unknown
-
2018
- 2018-04-23 AU AU2018202807A patent/AU2018202807B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112014000547A2 (en) | deoxycholic acid formulations and salts thereof | |
BR112015014477A2 (en) | zinc amino acid / trimethylglycine halide personal cleansing compositions | |
BR112013020620A2 (en) | 4-hydroxybutyric acid analogs | |
BR112013022495A2 (en) | tapentadol aqueous pharmaceutical formulation for oral administration | |
EA201590371A1 (en) | 1,4-DESIGNED PYRIDAZIN ANALOGUES AND METHODS OF TREATMENT RELATED TO SMN DEFICIENCY CONDITIONS | |
BR112013029240A2 (en) | deuterated ivacaftor derivatives | |
BR112013028907A2 (en) | protein-active agent conjugates and method for preparing same | |
BR112013000920A2 (en) | compounds for reducing beta-amyloid production | |
CL2013003057A1 (en) | Pharmaceutical aerosol composition in the form of an aqueous nebulization solution comprising iloprost, which provides an effective single dose aerosolized for bolus inhalation in a period of less than 2 minutes; Pharmaceutical kit, useful in the treatment of pulmonary arterial hypertension. | |
BR112014031204A2 (en) | deuterated derivatives of ruxolitinib | |
BR112014001802A2 (en) | well maintenance fluid and fluid well maintenance method | |
BR112013033008A8 (en) | liquid pharmaceutical composition comprising nitisinone | |
BR112014023423A2 (en) | combination therapy | |
MX2009007265A (en) | Salts, aqueous liquid compositions containing salts of s-(+)-abscisic acid and methods of their preparation. | |
BR112014010729A2 (en) | methods for treating gout attacks | |
BR112014004732A2 (en) | benzothiazolone compound | |
CY1115372T1 (en) | DOSOXYLIC ACID COMPOSITIONS AND ITS SALTS | |
BR112015014261A2 (en) | method for treating diseases | |
AR087371A1 (en) | FORMULATIONS OF (TRIMETOXIFENILAMINO) PYRIMIDINYL, METHODS | |
BR112013033060A2 (en) | ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol | |
BR112014016450A2 (en) | leukotriene b4 antagonist compound | |
SMT201300112B (en) | Citrate salt of 9E-15- (2-pyrrolidin-1-yl-ethoxy) -7,12,25-triossa-19,21,24-triaza-tetracycloÄ18.3.1.1 (2,5) .1 (14, 18) Üesacos a-1 (24), 2,4,9,14,16,18 (26), 20,22-nonaene | |
BR112018000538A2 (en) | hair shaping composition and methods for shaping hair and shaping and remolding hair | |
BR112013020195A2 (en) | citrate free pharmaceutical compositions comprising anakinra | |
BR112015005876A2 (en) | low melting propionic acid derived particles for use in oral dosage forms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B25D | Requested change of name of applicant approved |
Owner name: KYTHERA BIOPHARMACEUTICALS, LLC (US) |
|
B25G | Requested change of headquarter approved |
Owner name: KYTHERA BIOPHARMACEUTICALS, LLC (US) |
|
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 23/08/2011, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO. |
|
B25A | Requested transfer of rights approved |
Owner name: ALLERGAN SALES, LLC (US) |